Ketamine vs. SPRAVATO®: The Real Differences

The chemistry, in one paragraph

Ketamine as manufactured is a mixture of two mirror-image molecules. Esketamine — the "S" form — is one of them, isolated and developed as its own medication: the nasal spray sold as SPRAVATO®. So this isn't a comparison between a drug and something unrelated; it's a comparison between the original mixture and a purified relative that went through the FDA approval process for depression specifically.

The regulatory divide — where every practical difference starts

SPRAVATO® is FDA-approved for adults with treatment-resistant depression and for depressive symptoms in adults with major depressive disorder with acute suicidal thoughts or actions. Approval is what unlocks insurance coverage (commonly including Medicare, when criteria are met), and it comes packaged with a federally required safety program: certified treatment centers only, in-clinic self-administration under supervision, a post-dose observation period, and no take-home use — ever.

Generic ketamine for depression is prescribed off-label — legal and common, but outside any approval framework for depression. That means no standard insurance coverage (typically self-pay), no federally mandated delivery program, and clinic-by-clinic variation in route (IV infusion most traditionally), protocol, and monitoring practices. Reputable clinics supervise carefully anyway; the difference is that with SPRAVATO® the structure is required, and with generic ketamine it's the clinic's own standard.

The experience, compared

More alike than different: both produce dissociative effects — dreamlike detachment, altered perception — along with possible dizziness, nausea, and temporarily elevated blood pressure; both involve monitored sessions with a ride home; and for both, the session's intensity is not a measure of the treatment's benefit. Differences in feel are mostly about route and pacing: a nasal-spray dose followed by observation versus an infusion running over a set period. Patients who've done both describe the experiences as siblings, not strangers.

Cost and access, honestly

For patients who meet treatment-resistant depression criteria, SPRAVATO®'s coverage pathway usually makes it the affordable option — copays after prior authorization versus generic ketamine's cash pricing (commonly several hundred dollars per session, series totaling thousands). Access runs the other way: generic ketamine clinics don't require the certification infrastructure, so they're more numerous, and off-label prescribing gives physicians flexibility for cases outside SPRAVATO®'s approved indications. Full cost breakdown: How Much Does Ketamine Therapy Cost?

How the choice actually gets made

If you meet TRD criteria and have insurance, SPRAVATO®'s covered, structured pathway is usually the first conversation. If you don't fit the approved indications, insurance isn't in play, or a physician judges the infusion route better for your case, supervised generic ketamine is the flexible path. Either way, the non-negotiable is the word supervised — in-clinic, monitored, screened — because that structure, not the molecule, is what separates treatment from risk. A psychiatric evaluation is where the answer stops being general.